Advertisement

Topics

Pieris signs major Anticalin deal with AstraZeneca

15:40 EDT 4 May 2017 | Elsevier Business Intelligence

Pieris Pharmaceuticals Inc. signed its second major deal of the year involving its Anticalin protein therapies, this time wit...

Original Article: Pieris signs major Anticalin deal with AstraZeneca

NEXT ARTICLE

More From BioPortfolio on "Pieris signs major Anticalin deal with AstraZeneca"

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...